Answers are grounded in this paper and cite their sources.
Active MMP-2, CEC, and EPC levels and NK activity in participants that entered the maintenance phase (n = 16). Shown are the levels (cells/mL) at enrolment, upon induction, during maintenance, and post-therapy follow-up of active MMP-2 (A), CEC (B), and EPC (C), and NK-cell activity against K562 (D) or BCBL-1 targets (E) as % of lysis. Data are presented as box plots. Wilcoxon signed rank sum test for paired data and Mann–Whitney test were used for the analyses. P values assess the changes from enrolment and from baseline of maintenance within responders and progressors and differences between responders and progressors at each time point.
No takes yet. Share an insight, caveat, or question.
Sgadari et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: